Navigation Links
Nobel laureate claims the 2010 Herbert Tabor Lectureship

Phillip A. Sharp, a world leader of research in molecular biology and biochemistry and an institute professor at the Massachusetts Institute of Technology, has been named winner of the American Society for Biochemistry and Molecular Biology Herbert Tabor/Journal of Biological Chemistry Lectureship.

Sharp will give his award lecture, titled "The Biology of small RNAs," at the 2010 annual meeting at 6 p.m. Saturday, April 24, in Anaheim, Calif.

Sharp's research interests have centered on the molecular biology of gene expression relevant to cancer and the mechanisms of RNA splicing. His landmark achievement was the discovery of RNA splicing in 1977, for which he shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts.

"Phil's work has been characterized by a remarkable creativity -- he has literally broken open whole new fields -- and also by an equally remarkable track record for training outstanding scientists," said ASBMB President Gregory A. Petsko. "I can personally testify to his willingness to help young colleagues and to the generosity with which he has given his time to numerous good causes. He is a shining example of what a senior scientist should be."

Currently, Sharp has turned his attention to understanding RNA interference, the process by which RNA molecules act as switches to turn genes on and off. This recently discovered phenomenon has revolutionized biology and could potentially generate a new class of therapeutics.

Sharp did his undergraduate studies at Union College in Barbourville, Ky., where he majored in chemistry and mathematics, then completed his Ph.D. in chemistry at the University of Illinois at Urbana-Champaign in 1969, studying under noted physical chemist Victor Bloomfield.

While at the University of Illinois, Sharp read the 1966 volume of the Cold Spring Harbor Symposium on Quantitative Biology, titled "The Genetic Code," and became interested in molecular biology and genetics. He subsequently obtained a postdoctoral fellowship at the California Institute of Technology, where he studied the structure of sex factor and drug resistance plasmids in bacteria. In 1971, Sharp began a second postdoc, studying gene expression at the Cold Spring Harbor Laboratory under the renowned James D. Watson.

In 1974, Sharp joined MIT's Center for Cancer Research, now known as the David H. Koch Institute for Integrative Cancer Research, and has remained on the MIT campus ever since. He has held numerous leadership positions along the way: He was director of the Center for Cancer Research from 1985 to 1991, head of the biology department from 1991 to 1999 and director of the McGovern Institute for Brain Research from 2000 to 2004.

Sharp, who has authored more than 350 scientific papers, has received numerous awards and honorary degrees and has served on advisory boards for the government, academic institutions, scientific societies and companies. His other awards include the Gairdner Foundation International Award, the General Motors Research Foundation Alfred P. Sloan Jr. Prize for Cancer Research, the Albert Lasker Basic Medical Research Award, the National Medal of Science and the inaugural Double Helix Medal from the Cold Spring Harbor Laboratory. Sharp is a member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society.

In addition, Sharp is a co-founder of Biogen (now known as Biogen Idec) and Alnylam Pharmaceuticals.


Contact: Angela Hopp
American Society for Biochemistry and Molecular Biology

Related biology news :

1. Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
2. Professor Sir Martin Evans wins Nobel Prize for Medicine
3. Nobel Peace Prize 2007 to intergovernmental panel on climate change
4. Neilson member of Nobel Prize-winning panel of scientists
5. IOS Press congratulates IPCC with Nobel Peace Prize
6. Nobel laureate Dr. Linda Buck elected to American Academy of Arts & Sciences 2008 Class of Fellows
7. 55th anniversary of Nobel honoring double helix continues to overlook the late Rosalind Franklin
8. Nobel Laureate underscores importance of investment in basic research
9. UCSF scientist receives Nobel Prize in Physiology or Medicine
10. White House announces 2007 National Medal of Science laureates
11. Inaugural Kavli laureates honored in Oslo ceremony
Post Your Comments:
Related Image:
Nobel laureate claims the 2010 Herbert Tabor Lectureship
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today announced ... chief executive officer, will present at the 27 th ... New York City . The presentation will be webcast ... 9:30 a.m. EST. and go to ... 15 minutes prior to the presentation to allow for any ...
(Date:11/24/2015)... 24, 2015 According to two new studies, fewer ... is something that many doctors, scientists, and public health experts ... with fewer PSA tests being done, will there be more ... Dr. David Samadi, "Despite the efforts made in regards ... second leading cancer cause of death in men, killing approximately ...
(Date:11/23/2015)... 23, 2015 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its preliminary unaudited financial results for the second quarter ... 30, 2015. --> --> ... Revenues for the second quarter of fiscal 2016 increased ...
(Date:11/23/2015)... GENEVA , November 23, 2015 ... to develop daclatasvir for 112 ... countries   --> --> ... licence for a hepatitis C medicine, signing an agreement with ... proven to help cure multiple genotypes of the HCV virus. ...
Breaking Biology Technology: